From April 1^st, 2016, to March 31^st, 2017, 89 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,830,348 patient days (Table 1). Participating facilities reported 3,167 BSIs in 2,982 patients. The total incidence rate was 5.43 cases per 10,000 patient days. The incidence rate in 2016–2017 is stable compared with the average rate for 2012–2016. Two non-teaching facilities joined the program in 2016–2017....

From April 1^st, 2016, to March 31^st, 2017, 82 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 4,448,999 patient days (Table 1). These facilities reported 17 healthcare-associated CPGNB (HA-CPGNB) infections among patients who acquired their strain during a current or previous hospitalization (categories 1a and 1b). The incidence rate of HA-CPGNB infection was 0.04 per 10,000 patient days. The...

From April 1^st, 2016 to March 31^st, 2017, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,835,605 patient days (Table 1). Together, these facilities reported 66 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI) acquired during a current or previous hospitalization (categories 1a and 1b). The HA-MRSA-BSI incidence rate was 0.14...

Entre le 1^er avril 2016 et le 31 mars 2017, 89 installations de santé ont participé à la surveillance des bactériémies à Staphylococcus aureus résistant à la méthicilline (SARM), pour un cumul de 4 835 605 jours-présence (tableau 1). Ces installations ont rapporté 66 bactériémies nosocomiales à SARM. Le taux d’incidence des bactériémies nosocomiales à SARM est de 0,14 / 10 000 jours-présence. Alors que ce taux d’incidence évolue à la baisse depuis...